Rajesh Basnet - University of Chinese Academy of Sciences;Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences

基本信息

Career Trajectory

Bio

Rajesh Basnet received his B.Pharm, Institute of Medicine, Tribhuvan University, and MSc. In Pharmacology, Shanghai Institute of Materia Medica, Shanghai (2019). He was awarded a UCAS scholarship (2016). His research interests in drug discovery of cancer and gout.

Research Interests

Papers共 25 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Enhancing Antitumor Response by Efficiently Generating Large-Scale TCR-T Cells Targeting a Single Epitope Across Multiple Cancer Antigens

Obed Boadi Amissah,Rajesh Basnet, Wenfang Chen,Jean de Dieu Habimana, Belinda Edwina Baiden, Osei Asibey Owusu, Babangida Jabir Saeed,Zhiyuan Li

CELLULAR IMMUNOLOGY (2024)

Cited0Views0WOSBibtex

Network Pharmacology-Based Virtual Screening of Chemical Constituents from Vitexnegundo Linn's Discovered Novel Molecular Targets for Breast Cancer Treatment

Rajesh Basnet,Buddha Bahadur Basnet,Obed Boadi Amissah,Rongqi Huang,Yirong Sun,Jean de Dieu Habimana,Zhiyuan Li

Current cancer drug targets (2024)

Cited0Views0WOSBibtex

Molecular Mechanisms of Resistance and Treatment Efficacy of Clofazimine and Bedaquiline Against Mycobacterium Tuberculosis

Md Mahmudul Islam,Md Shah Alam,Zhiyong Liu,Mst Sumaia Khatun,Buhari Yusuf,H. M. Adnan Hameed,Xirong Tian,Chiranjibi Chhotaray,Rajesh Basnet, Haftay Abraha, Xiaofan Zhang,Shahzad Akbar Khan,Cuiting Fang, Chunyu Li,Sohel Hasan,Shouyong Tan,Nanshan Zhong,Jinxing Hu,Tianyu Zhang

Frontiers in Medicine（2024）

Cited1Views0WOSBibtex

Potential Target of CDK6 Signaling Pathway for Cancer Treatment

Rajesh Basnet,Obed Boadi Amissah,Buddha Bahadur Basnet,Rongqi Huang,Yirong Sun,Jean de Dieu Habimana,Zhiyuan Li

Current drug targetsno. 11 (2024): 724-739

Cited0Views0WOSBibtex

NY-ESO-1-specific T Cell Receptor-Engineered T Cells and Tranilast, a TRPV2 Antagonist Bivalent Treatment Enhances the Killing of Esophageal Cancer: a Dual-Targeted Cancer Therapeutic Route

Obed Boadi Amissah, Wenfang Chen,Jean de Dieu Habimana,Yirong Sun,Lihui Lin,Yujie Liu, Ling Wang,Zhaoming Liu,Omar Mukama,Rajesh Basnet, Hohua Liu, Junyi Li,Xuanyan Ding, Lingshuang Lv,Min Chen, Yalin Liang,Rongqi Huang,Zhiyuan Li

Cancer Cell Internationalno. 1 (2024)

Cited3Views0WOSBibtex

Mammalian Target of Rapamycin (mtor) Signalling Pathway-A Potential Target for Cancer Intervention: A Short Overview

Rajesh Basnet,Buddha Bahadur Basnet,Radheshyam Gupta,TilBahadur Basnet,Sandhya Khadka, Md Shan Alam

Current molecular pharmacology（2024）

Cited3Views0WOSBibtex

Maternal High Fat Diet and Its Expressions in the Heart and Liver in the Mice Embryogenesis

Sanjeev Nirala,Xue-Rui Tan,Muhammad Shafiq,Rajesh Basnet, Apekshya Singh

Current Molecular Medicineno. 7 (2023): 889-898

Cited0Views0WOSBibtex

Interaction Between Gut Microbiota Metabolites and Dietary Components in Lipid Metabolism and Metabolic Diseases

Til Bahadur Basnet,Srijana Gc,Rajesh Basnet,Sadia Fatima,Mahpara Safdar,Bismillah Sehar,Ali Saad R Alsubaie,Falak Zeb

Access microbiologyno. 6 (2023): acmi000403-acmi000403

Cited3Views0WOSBibtex

Overview of Drug Therapy of COVID-19 with Safety and the Potential Clinical Benefits

Rajesh Basnet,Sandhya Khadka,Buddha Bahadur Basnet,Til Bahadur Basnet,Sanjeep Sapkota

CURRENT DRUG THERAPY（2022）

Cited0Views0Bibtex

The Prevalence of Subclinical Hypothyroidism in the Obese Population and Effect Following Bariatric Surgery

Radheshyam Gupta,Jiangfan Zhu,Yao Yang,Pamesh Jha,Rajesh Basnet,Ma Chiye

American Journal of Health Researchno. 1 (2022)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn